Antiviral immunity: LGP2 rigs CD8 +T cells for survival

Nature Reviews Immunology

Volumn 12, Issue 9, 2012, Pages 616-

  Leavy, Olive ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; FAS LIGAND; LGP2 PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG;

ANTIVIRAL IMMUNITY; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CONTROLLED STUDY; DENDRITIC CELL; EFFECTOR CELL; IMMUNITY; IN VITRO STUDY; INNATE IMMUNITY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MACROPHAGE; MOUSE; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS LOAD; VIRUS REPLICATION; WEST NILE FLAVIVIRUS;

EID: 84866431030     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3286     Document Type: Note

References (2)

1. Suthar, M. S. et al. The RIG-I-like receptor LGP2 controls CD8+ T cell survival and fitness. Immunity 26 Jul 2012 (doi:10.1016/j.immuni.2012.07.004)
2. Desmet, C. J. & Ishii, K. J. Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination. Nature Rev. Immunol. 12, 479-491 (2012)